(Q33859242)

29 July 2017

title

One-year follow-up of quality of life in adults with untreated growth hormone deficiency (English)

1 reference

29 July 2017

Badia X

1

1 reference

29 July 2017

Lucas A

2

1 reference

29 July 2017

Sanmartí A

3

1 reference

29 July 2017

Roset M

4

1 reference

29 July 2017

Ulied A

5

1 reference

29 July 2017

publication date

1 December 1998

1 reference

29 July 2017

published in

Clinical Endocrinology

1 reference

29 July 2017

volume

49

1 reference

29 July 2017

issue

6

1 reference

29 July 2017

page(s)

765-771

1 reference

Effects of growth hormone substitution on mental performance in adults with growth hormone deficiency: a pilot study.

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Using the EuroQoI 5-D in the Catalan general population: feasibility and construct validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Quality of life in adults with growth hormone (GH) deficiency: response to treatment with recombinant human GH in a placebo-controlled 21-month trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Human growth hormone replacement therapy: pharmacological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Growth hormone deficiency and quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Quality-of-life assessment of adults with growth hormone deficiency. Implications for drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Consequences of growth hormone deficiency in adults and the benefits and risks of recombinant human growth hormone treatment. A review paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Decreased psychological well-being in adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

The development, reliability and validity of a disease specific quality of life model for adults with growth hormone deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.1998.00634.X

10.1046/J.1365-2265.1998.00634.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference